All Stories

  1. Population- and haplotype-dependent variation around TYR rs1126809: an in silico study suggesting new directions for melanoma risk research
  2. A Novel Germline Frameshift Variant in the Tumor Suppressor Gene OBSCN in a Melanoma Patient
  3. Truncating CYLD Pathogenic Variants in CYLD Cutaneous Syndrome Distinctly Influence CYLD Proteostasis and NF-κB Signaling
  4. Timely recognition of a probably life-threatening genodermatosis: familial case report of hereditary leiomyomatosis and renal cell cancer
  5. Novel Pathogenic Variant of the TRRAP Gene Detected in a Hungarian Family with Autosomal Dominant Non-Syndromic Hearing Loss
  6. Novel Pathogenic Variant of the TRRAP Gene Detected in a Hungarian Family with Autosomal Dominant Non-Syndromic Hearing Loss
  7. Novel FANCI and RAD54B Variants and the Observed Clinical Outcomes in a Hungarian Melanoma Cohort
  8. Novel Variants in Medium and Low Penetrance Predisposing Genes in a Hungarian Malignant Melanoma Cohort With Increased Risk
  9. Missing Heritability in Albinism: Deep Characterization of a Hungarian Albinism Cohort Raises the Possibility of the Digenic Genetic Background of the Disease
  10. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder
  11. Whole-Exome Sequencing Identified Two Novel Pathogenic Mutations in the PTCH1 Gene in BCNS
  12. Genetic Etiology of Nonsyndromic Hearing Loss in Hungarian Patients
  13. Homozygous ITGA3 Missense Mutation in Adults in a Family with Syndromic Epidermolysis Bullosa (ILNEB) without Pulmonary Involvement
  14. Genetic Testing in CYLD Cutaneous Syndrome: An Update
  15. Report of a Novel ALOX12B Mutation in Self-Improving Collodion Ichthyosis with an Overview of the Genetic Background of the Collodion Baby Phenotype
  16. TRAF3 and NBR1 both influence the effect of the disease‐causing CYLD(Arg936X) mutation on NF‐κB activity
  17. Identification of putative phenotype‐modifying genetic factors associated with phenotypic diversity in Brooke‐Spiegler syndrome
  18. Identification of putative genetic modifying factors that influence the development of Papillon–Lefévre or Haim–Munk syndrome phenotypes
  19. Identification of putative phenotype-modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome
  20. A novel nonsense mutation of the CYLD gene in a Turkish family with multiple familial trichoepithelioma
  21. A comparative analysis of national Olympic swimming team members’ and para-swimming team members’ psychological profiles
  22. Brooke–Spiegler Syndrome: Two Patients From a Turkish Family With Multiple Familial Trichoepithelioma
  23. 304 Identification of putative genetic modifying factors influencing the development of Papillon-Lefévre or Haim-Munk syndrome phenotypes
  24. 305 Putative phenotype modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome
  25. The management and genetic background of pityriasis rubra pilaris: a single‐centre experience
  26. A novel WDR62 missense mutation in microcephaly with abnormal cortical architecture and review of the literature
  27. Genetic investigation confirmed the clinical phenotype of congenital chloride diarrhea in a Hungarian patient: a case report
  28. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis
  29. Nuclear Factor κB Activation in a Type V Pityriasis Rubra Pilaris Patient Harboring Multiple CARD14 Variants
  30. Phenotypic diversity of the recurrent p.Val379Leu missense mutation of the TGM1 gene
  31. 472 CARD14 variants in pityriasis rubra pilaris
  32. The rs13388259 Intergenic Polymorphism in the Genomic Context of theBCYRN1Gene Is Associated with Parkinson’s Disease in the Hungarian Population
  33. 233 Identification of genetic modifying factors responsible for the development of the distinct Papillon-Lefévre syndrome and Haim-Munk syndrome clinical phenotypes
  34. 318 The functional characterization of CARD14 variants in pityriasis rubra pilaris affected skin and keratinocytes
  35. A nagyobb méretű géndeletiók jelentősége a sclerosis tuberosa diagnosztikájában: az első magyar esetek bemutatása
  36. Delineating the genetic heterogeneity of OCA in Hungarian patients
  37. Atypical neurofibromatosis type 1 with unilateral limb hypertrophy mimicking overgrowth syndrome
  38. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis
  39. High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis
  40. Identification of two novel mutations in the SLC45A2 gene in a Hungarian pedigree affected by unusual OCA type 4
  41. Electrochemotherapy for Non-melanoma Skin Cancer in a Child with Xeroderma Pigmentosum
  42. Epidermolyticus ichthyosis
  43. Pharmacological Targeting of the Epidermal Barrier
  44. 168 Genetic investigations in the CYLD mutation-caused disease spectrum
  45. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex
  46. Somatic mosaicism of the PIK3CA gene identified in a Hungarian girl with macrodactyly and syndactyly
  47. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene
  48. Analysis of urinary cathepsin C for diagnosing Papillon–Lefèvre syndrome
  49. Phenotypical diversity of patients with LEOPARD syndrome carrying the worldwide recurrent p.Tyr279Cys PTPN11 mutation
  50. The clinical manifestations of two novel SPAST mutations
  51. One mutation, two phenotypes: a single nonsense mutation of theCTSCgene causes two clinically distinct phenotypes
  52. A jéghegy csúcsa: multiplex faggyúmirigy-eredetű bőrtumor coloncarcinomában. Muir–Torre-szindróma
  53. CYLD and Brooke-Spiegler syndrome, familial cylindromatosis and thrichoeptheliomatosis
  54. Multiple familial trichoepithelioma: Report of a Spanish family associated with a mutation in the CYLD gene
  55. Knowledge explosion for monogenic skin diseases
  56. Identification of Two Novel Mutations in the SLC45A2 Gene in a Hungarian Pedigree Affected by Unusual OCA Type 4
  57. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes
  58. Difficulties of genetic counselling in rare, mainly neurogenetic disorders
  59. Identification of a novel missense GLRA1 gene mutation in hyperekplexia: a case report
  60. Ulcus vulvae acutum Lipschütz in two young female patients
  61. CTSC and Papillon-Lefevre syndrome
  62. Nemaline Myopathy Type 2 (NEM2)
  63. A newly identified missense mutation of the EDA1 gene in a Hungarian patient with Christ–Siemens–Touraine syndrome
  64. A novel seven-base deletion of the CTSC gene identified in a Hungarian family with Papillon-Lefèvre syndrome
  65. A Mutational Hotspot in CYLD Causing Cylindromas: A Comparison of Phenotypes Arising in Different Genetic Backgrounds
  66. Early detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of comparable cases
  67. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke–Spiegler syndrome
  68. A newly identified missense mutation of the HR gene is associated with a novel, unusual phenotype of Marie Unna Hereditary Hypotrichosis 1 including limb deformities
  69. Mechanisms of IFN-γ–induced apoptosis of human skin keratinocytes in patients with atopic dermatitis
  70. MiR‐21 is up‐regulated in psoriasis and suppresses T cell apoptosis
  71. Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
  72. Successful Treatment of Multiple Basaliomas with Bleomycin-based Electrochemotherapy: A Case Series of Three Patients with Gorlin-Goltz Syndrome
  73. HB-EGF induces COL7A1 expression
  74. MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2
  75. Intra-familial Variability of Ectodermal Defects Associated with WNT10A Mutations
  76. Strontium Ranelate-induced DRESS Syndrome with Persistent Autoimmune Hepatitis
  77. Revertant Mosaicism
  78. Schöpf-Schulz-Passarge syndrome resulting from a homozygous nonsense mutation in WNT10A
  79. Identification of a homozygous deletion mutation in C16orf57 in a family with Clericuzio‐type poikiloderma with neutropenia
  80. New perspective in immunotherapy: local imiquimod treatment
  81. New insights into hereditary angio-oedema: Molecular diagnosis and therapy
  82. The molecular skin pathology of familial primary localized cutaneous amyloidosis
  83. The anti‐apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non‐coding RNA, PRINS
  84. Blistering skin diseases: a bridge between dermatopathology and molecular biology
  85. Common IL-31 Gene Haplotype Associated with Non-atopic Eczema is Not Implicated in Epidermolysis Bullosa Pruriginosa
  86. Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema
  87. The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer
  88. The Arg160Trp Allele of Melanocortin‐1 Receptor Gene Might Protect Against Vitiligo†
  89. Tumor Necrosis Factor-α −308 Polymorphism and Leg Ulceration – Possible Association with Obesity
  90. The expression of keratinocyte growth factor receptor (FGFR2‐IIIb) correlates with the high proliferative rate of HaCaT keratinocytes
  91. Single Nucleotide Polymorphisms of the Fibroblast Growth Factor Receptor 2 Gene in Patients with Chronic Venous Insufficiency with Leg Ulcer
  92. Optimal Adrenergic Support in Septic Shock Due to Peritonitis
  93. EFFECTS OF PENTASTARCH RESUSCITATION IN SEPTIC SHOCK